format-version: 1.4
auto-generated-by: PyOBO v0.12.5-dev-2c1432a8 on 2025-08-19T02:34:10.904993
idspace: cpt https://www.aapc.com/codes/cpt-codes/ "Current Procedural Terminology"
idspace: cvx https://biopragmatics.github.io/providers/cvx/ "Vaccine administered code set"
idspace: dcterms http://purl.org/dc/terms/ "Dublin Core Metadata Initiative Terms"
idspace: foaf http://xmlns.com/foaf/0.1/ "Friend of a Friend"
ontology: cpt
property_value: dcterms:title "Current Procedural Terminology" xsd:string
property_value: dcterms:description "Current Procedural Terminology\, more commonly known as CPT®\, refers to a medical code set created and maintained by the American Medical Association — and used by physicians\, allied health professionals\, nonphysician practitioners\, hospitals\, outpatient facilities\, and laboratories to represent the services and procedures they perform. No provider of outpatient services gets paid without reporting the proper CPT® codes. \[Description taken from this site\]\(https\://www.aapc.com/codes/cpt-codes-range/\)\]" xsd:string
property_value: foaf:homepage "https\://www.aapc.com" xsd:anyURI
property_value: foaf:logo "https\://edhub.ama-assn.org/ImageLibrary/Ed-Hub-Self-Serve/CPT-monogram.png" xsd:anyURI

[Term]
id: cpt:90281
name: IG
def: "Immune globulin \(Ig\)\, human\, for intramuscular use"
xref: cvx:86

[Term]
id: cpt:90283
name: IGIV
def: "Immune globulin \(IgIV\)\, human\, for intravenous use"
xref: cvx:87

[Term]
id: cpt:90287
name: botulinum antitoxin
def: "Botulinum antitoxin\, equine\, any route"
xref: cvx:27

[Term]
id: cpt:90291
name: CMVIG
def: "Cytomegalovirus immune globulin \(CMV-IgIV\)\, human\, for intravenous use"
xref: cvx:29

[Term]
id: cpt:90296
name: diphtheria antitoxin
def: "Diphtheria antitoxin\, equine\, any route"
xref: cvx:12

[Term]
id: cpt:90371
name: HBIG
def: "Hepatitis B immune globulin \(HBIg\)\, human\, for intramuscular use"
xref: cvx:30

[Term]
id: cpt:90375
name: RIG
def: "Rabies immune globulin \(RIg\)\, human\, for intramuscular and/or subcutaneous use"
xref: cvx:34

[Term]
id: cpt:90376
name: RIG
def: "Rabies immune globulin\, heat-treated \(RIg-HT\)\, human\, for intramuscular and/or subcutaneous use"
xref: cvx:34

[Term]
id: cpt:90378
name: RSV-MAb
def: "Respiratory syncytial virus\, monoclonal antibody\, recombinant\, for intramuscular use\, 50 mg\, each"
xref: cvx:93

[Term]
id: cpt:90380
name: RSV\, mAb\, nirsevimab-alip\, 0.5 mL\, neonate to 24 months
def: "Respiratory syncytial virus\, monoclonal antibody\, seasonal dose; 0.5 mL dosage\, for intramuscular use"
comment: "CPT Code to be used for Beyfortus 0.5 mL"
xref: cvx:306

[Term]
id: cpt:90381
name: RSV\, mAb\, nirsevimab-alip\, 1 mL\, neonate to 24 months
def: "Respiratory syncytial virus\, monoclonal antibody\, seasonal dose; 1 mL dosage\, for intramuscular use"
comment: "CPT Code to be used for Beyfortus 1.0 mL"
xref: cvx:307

[Term]
id: cpt:90382
name: RSV\, mAb\, clesrovimab-cfor\, 0.7 mL\, neonate and infant\, PF
def: "Respiratory syncytial virus\, monoclonal antibody\, seasonal dose\, 0.7 mL\, for intramuscular use"
xref: cvx:332

[Term]
id: cpt:90389
name: TIG
def: "Tetanus immune globulin \(TIg\)\, human\, for intramuscular use"
xref: cvx:13

[Term]
id: cpt:90393
name: vaccinia immune globulin
def: "Vaccinia immune globulin\, human\, for intramuscular use"
xref: cvx:79

[Term]
id: cpt:90396
name: VZIG
def: "Varicella-zoster immune globulin\, human\, for intramuscular use"
xref: cvx:36

[Term]
id: cpt:90470
name: Novel Influenza-H1N1-09\, all formulations
def: "H1N1 immunization administration \(intramuscular\, intranasal\)\, including counseling when performed"
xref: cvx:128

[Term]
id: cpt:90476
name: adenovirus\, type 4
def: "Adenovirus vaccine\, type 4\, live\, for oral use"
xref: cvx:54

[Term]
id: cpt:90477
name: adenovirus\, type 7
def: "Adenovirus vaccine\, type 7\, live\, for oral use"
xref: cvx:55

[Term]
id: cpt:90581
name: Anthrax\, post-exposure prophylaxis
def: "Anthrax vaccine\, for subcutaneous or intramuscular use"
xref: cvx:318

[Term]
id: cpt:90581
name: Anthrax\, pre-exposure prophylaxis\, post-exposure prophylaxis
def: "Anthrax vaccine\, for subcutaneous or intramuscular use"
xref: cvx:24

[Term]
id: cpt:90585
name: BCG
def: "Bacillus Calmette-Guerin vaccine \(BCG\) for tuberculosis\, live\, for percutaneous use"
xref: cvx:19

[Term]
id: cpt:90587
name: dengue fever tetravalent
def: "Dengue vaccine\, quadrivalent\, live\, 3 dose schedule\, for subcutaneous use"
xref: cvx:56

[Term]
id: cpt:90589
name: Chikungunya live attenuated vaccine\, 0.5 mL\, PF
def: "Chikungunya virus vaccine\, live attenuated\, for intramuscular use"
xref: cvx:317

[Term]
id: cpt:90593
name: Chikungunya\, VLP\, recombinant\, 0.8 mL\, PF
def: "Chikungunya virus vaccine\, recombinant\, for intramuscular use"
xref: cvx:329

[Term]
id: cpt:90611
name: Vaccinia\, smallpox Mpox vaccine live\, PF\, SQ or ID injection
def: "Smallpox and monkeypox vaccine\, attenuated vaccinia virus\, live\, non-replicating\, preservative free\, 0.5 mL dosage\, suspension\, for subcutaneous use"
comment: "CPT Code to be used for JYNNEOS vaccine"
xref: cvx:206

[Term]
id: cpt:90619
name: meningococcal conjugate quadrivalent\, MenACWY-TT \(MCV4\)
def: "Meningococcal conjugate vaccine\, serogroups A\, C\, W\, Y\, quadrivalent\, tetanus toxoid carrier \(MenACWY-TT\)\, for intramuscular use"
xref: cvx:203

[Term]
id: cpt:90620
name: meningococcal B\, OMV
def: "Meningococcal recombinant protein and outer membrane vesicle vaccine\, serogroup B \(MenB-4C\)\, for intramuscular use"
xref: cvx:163

[Term]
id: cpt:90621
name: meningococcal B\, recombinant
def: "Meningococcal recombinant lipoprotein vaccine\, serogroup B \(MenB-FHbp\)\, 2 or 3 dose schedule\, for intramuscular use"
xref: cvx:162

[Term]
id: cpt:90622
name: Vaccinia \(smallpox\, mpox\)\, live
def: "Vaccinia \(smallpox\) virus vaccine\, live\, lyophilized\, 0.3 mL dosage\, for percutaneous use"
comment: "CPT Code to be used for ACAM2000 vaccine"
xref: cvx:75

[Term]
id: cpt:90623
name: Meningococcal polysaccharide \(MenACWY-TT conjugate\)\, \(MenB\)\, PF
def: "Meningococcal pentavalent vaccine\, conjugated Men A\, C\, W\, Y- tetanus toxoid carrier\, and Men B-FHbp\, for intramuscular use"
xref: cvx:316

[Term]
id: cpt:90624
name: Meningococcal oligosaccharide \(MenACWY\)\, \(MenB\)\, PF
def: "Meningococcal pentavalent vaccine\, Men B-4C recombinant proteins and outer membrane vesicle and conjugated Men A\, C\, W\, Y-diphtheria toxoid carrier\, for intramuscular use"
xref: cvx:328

[Term]
id: cpt:90625
name: cholera\, live attenuated
def: "Cholera vaccine\, live\, adult dosage\, 1 dose schedule\, for oral use"
xref: cvx:174

[Term]
id: cpt:90626
name: Tick-borne encephalitis\, inactivated\, PF\, 0.25mL
def: "Tick-borne encephalitis virus vaccine\, inactivated; 0.25 mL dosage\, for intramuscular use"
xref: cvx:223

[Term]
id: cpt:90627
name: Tick-borne encephalitis\, inactivated\, PF\, 0.5mL
def: "Tick-borne encephalitis virus vaccine\, inactivated; 0.5 mL dosage\, for intramuscular use"
xref: cvx:224

[Term]
id: cpt:90630
name: influenza\, intradermal\, quadrivalent\, preservative free
def: "Influenza virus vaccine\, quadrivalent \(IIV4\)\, split virus\, preservative free\, for intradermal use"
xref: cvx:166

[Term]
id: cpt:90632
name: Hep A\, adult
def: "Hepatitis A vaccine \(HepA\)\, adult dosage\, for intramuscular use"
xref: cvx:52

[Term]
id: cpt:90633
name: Hep A\, ped/adol\, 2 dose
def: "Hepatitis A vaccine \(HepA\)\, pediatric/adolescent dosage-2 dose schedule\, for intramuscular use"
xref: cvx:83

[Term]
id: cpt:90634
name: Hep A\, ped/adol\, 3 dose
def: "Hepatitis A vaccine \(HepA\)\, pediatric/adolescent dosage-3 dose schedule\, for intramuscular use"
xref: cvx:84

[Term]
id: cpt:90636
name: Hep A-Hep B
def: "Hepatitis A and hepatitis B vaccine \(HepA-HepB\)\, adult dosage\, for intramuscular use"
xref: cvx:104

[Term]
id: cpt:90644
name: Meningococcal C/Y-HIB PRP
def: "Meningococcal conjugate vaccine\, serogroups C & Y and Haemophilus influenzae type b vaccine \(Hib-MenCY\)\, 4 dose schedule\, when administered to children 6 weeks-18 months of age\, for intramuscular use"
xref: cvx:148

[Term]
id: cpt:90645
name: Hib \(HbOC\)
def: "Hemophilus influenza b vaccine \(Hib\)\, HbOC conjugate \(4 dose schedule\)\, for intramuscular use"
xref: cvx:47

[Term]
id: cpt:90646
name: Hib \(PRP-D\)
def: "Hemophilus influenza b vaccine \(Hib\)\, PRP-D conjugate\, for booster use only\, intramuscular use"
xref: cvx:46

[Term]
id: cpt:90647
name: Hib \(PRP-OMP\)
def: "Haemophilus influenzae type b vaccine \(Hib\)\, PRP-OMP conjugate\, 3 dose schedule\, for intramuscular use"
xref: cvx:49

[Term]
id: cpt:90648
name: Hib \(PRP-T\)
def: "Haemophilus influenzae type b vaccine \(Hib\)\, PRP-T conjugate\, 4 dose schedule\, for intramuscular use"
xref: cvx:48

[Term]
id: cpt:90649
name: HPV\, quadrivalent
def: "Human Papillomavirus vaccine\, types 6\, 11\, 16\, 18\, quadrivalent \(4vHPV\)\, 3 dose schedule\, for intramuscular use"
xref: cvx:62

[Term]
id: cpt:90650
name: HPV\, bivalent
def: "Human Papillomavirus vaccine\, types 16\, 18\, bivalent \(2vHPV\)\, 3 dose schedule\, for intramuscular use"
xref: cvx:118

[Term]
id: cpt:90651
name: HPV9
def: "Human Papillomavirus vaccine types 6\, 11\, 16\, 18\, 31\, 33\, 45\, 52\, 58\, nonavalent \(9vHPV\)\, 2 or 3 dose schedule\, for intramuscular use"
xref: cvx:165

[Term]
id: cpt:90653
name: Influenza\, adjuvanted\, trivalent\, PF
def: "Influenza vaccine\, inactivated \(IIV\)\, subunit\, adjuvanted\, for intramuscular use"
xref: cvx:168

[Term]
id: cpt:90654
name: influenza\, seasonal\, intradermal\, preservative free
def: "Influenza virus vaccine\, trivalent \(IIV3\)\, split virus\, preservative-free\, for intradermal use"
xref: cvx:144

[Term]
id: cpt:90656
name: Influenza\, split virus\, trivalent\, PF
def: "Influenza virus vaccine\, trivalent \(IIV3\)\, split virus\, preservative free\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:140

[Term]
id: cpt:90657
name: Influenza\, split virus\, trivalent\, preservative
def: "Influenza virus vaccine\, trivalent \(IIV3\)\, split virus\, 0.25 mL dosage\, for intramuscular use"
xref: cvx:141

[Term]
id: cpt:90658
name: Influenza\, split virus\, trivalent\, preservative
def: "Influenza virus vaccine\, trivalent \(IIV3\)\, split virus\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:141

[Term]
id: cpt:90659
name: influenza\, whole
def: "Influenza virus vaccine\, whole virus\, for intramuscular or jet injection use"
xref: cvx:16

[Term]
id: cpt:90660
name: Influenza\, live\, trivalent\, intranasal\, PF
def: "Influenza virus vaccine\, trivalent\, live \(LAIV3\)\, for intranasal use"
xref: cvx:111

[Term]
id: cpt:90661
name: Influenza\, MDCK\, trivalent\, PF
def: "Influenza virus vaccine\, trivalent \(ccIIV3\)\, derived from cell cultures\, subunit\, antibiotic free\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:153

[Term]
id: cpt:90661
name: Influenza\, MDCK\, trivalent\, preservative
def: "Influenza virus vaccine\, trivalent \(ccIIV3\)\, derived from cell cultures\, subunit\, antibiotic free\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:320

[Term]
id: cpt:90662
name: Influenza\, high-dose\, trivalent\, PF
def: "Influenza virus vaccine \(IIV\)\, split virus\, preservative free\, enhanced immunogenicity via increased antigen content\, for intramuscular use"
xref: cvx:135

[Term]
id: cpt:90662
name: Influenza\, high-dose\, quadrivalent\, PF
def: "Influenza virus vaccine \(IIV\)\, split virus\, preservative free\, enhanced immunogenicity via increased antigen content\, for intramuscular use"
xref: cvx:197

[Term]
id: cpt:90663
name: Novel Influenza-H1N1-09\, all formulations
def: "Influenza virus vaccine\, pandemic formulation\, H1N1"
xref: cvx:128

[Term]
id: cpt:90664
name: Novel Influenza-H1N1-09\, nasal
def: "Influenza virus vaccine\, live \(LAIV\)\, pandemic formulation\, for intranasal use"
xref: cvx:125

[Term]
id: cpt:90665
name: Lyme disease
def: "Lyme disease vaccine\, adult dosage\, for intramuscular use"
xref: cvx:66

[Term]
id: cpt:90666
name: Novel influenza-H1N1-09\, preservative-free
def: "Influenza virus vaccine \(IIV\)\, pandemic formulation\, split virus\, preservative free\, for intramuscular use"
xref: cvx:126

[Term]
id: cpt:90668
name: Novel influenza-H1N1-09
def: "Influenza virus vaccine \(IIV\)\, pandemic formulation\, split virus\, for intramuscular use"
xref: cvx:127

[Term]
id: cpt:90669
name: pneumococcal conjugate PCV 7
def: "Pneumococcal conjugate vaccine\, 7 valent\, for intramuscular use"
xref: cvx:100

[Term]
id: cpt:90670
name: Pneumococcal conjugate PCV 13
def: "Pneumococcal conjugate vaccine\, 13 valent \(PCV13\)\, for intramuscular use"
xref: cvx:133

[Term]
id: cpt:90671
name: Pneumococcal conjugate PCV15\, polysaccharide CRM197 conjugate\, adjuvant\, PF
def: "Pneumococcal conjugate vaccine\, 15 valent \(PCV15\)\, for intramuscular use"
xref: cvx:215

[Term]
id: cpt:90672
name: Influenza\, live\, quadrivalent\, intranasal
def: "Influenza virus vaccine\, quadrivalent\, live \(LAIV4\)\, for intranasal use"
xref: cvx:149

[Term]
id: cpt:90673
name: Influenza\, recombinant\, trivalent\, PF
def: "Influenza virus vaccine\, trivalent \(RIV3\)\, derived from recombinant DNA\, hemagglutinin \(HA\) protein only\, preservative and antibiotic free\, for intramuscular use"
xref: cvx:155

[Term]
id: cpt:90674
name: Influenza\, MDCK\, quadrivalent\, PF
def: "Influenza virus vaccine\, quadrivalent \(ccIIV4\)\, derived from cell cultures\, subunit\, preservative and antibiotic free\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:171

[Term]
id: cpt:90675
name: Rabies - IM Diploid cell culture
def: "Rabies vaccine\, for intramuscular use"
xref: cvx:175

[Term]
id: cpt:90675
name: Rabies - IM fibroblast culture
def: "Rabies vaccine\, for intramuscular use"
xref: cvx:176

[Term]
id: cpt:90676
name: rabies\, intradermal injection
def: "Rabies vaccine\, for intradermal use"
xref: cvx:40

[Term]
id: cpt:90677
name: Pneumococcal conjugate PCV20\, polysaccharide CRM197 conjugate\, adjuvant\, PF
def: "Pneumococcal conjugate vaccine\, 20 valent \(PCV20\)\, for intramuscular use"
xref: cvx:216

[Term]
id: cpt:90678
name: RSV\, bivalent\, protein subunit RSVpreF\, diluent reconstituted\, 0.5 mL\, PF
def: "Respiratory syncytial virus vaccine\, preF\, subunit\, bivalent\, for intramuscular use"
comment: "CPT Code to be used for ABRYSVO"
xref: cvx:305

[Term]
id: cpt:90679
name: RSV\, recombinant\, protein subunit RSVpreF\, adjuvant reconstituted\, 0.5 mL\, PF
def: "Respiratory syncytial virus vaccine\, preF\, recombinant\, subunit\, adjuvanted\, for intramuscular use"
comment: "CPT Code to be Used for Arexvy"
xref: cvx:303

[Term]
id: cpt:90680
name: rotavirus\, pentavalent
def: "Rotavirus vaccine\, pentavalent \(RV5\)\, 3 dose schedule\, live\, for oral use"
xref: cvx:116

[Term]
id: cpt:90681
name: rotavirus\, monovalent
def: "Rotavirus vaccine\, human\, attenuated \(RV1\)\, 2 dose schedule\, live\, for oral use"
xref: cvx:119

[Term]
id: cpt:90682
name: Influenza\, recombinant\, quadrivalent\, PF
def: "Influenza virus vaccine\, quadrivalent \(RIV4\)\, derived from recombinant DNA\, hemagglutinin \(HA\) protein only\, preservative and antibiotic free\, for intramuscular use"
xref: cvx:185

[Term]
id: cpt:90683
name: RSV\, mRNA\, injectable\, PF
def: "Respiratory syncytial virus vaccine\, mRNA lipid nanoparticles\, for intramuscular use"
xref: cvx:326

[Term]
id: cpt:90684
name: Pneumococcal conjugate PCV21\, polysaccharide CRM197 conjugate\, PF
def: "Pneumococcal conjugate vaccine\, 21 valent \(PCV21\)\, for intramuscular use"
xref: cvx:327

[Term]
id: cpt:90685
name: Influenza\, injectable\,quadrivalent\, preservative free\, pediatric
def: "Influenza virus vaccine\, quadrivalent \(IIV4\)\, split virus\, preservative free\, 0.25 mL dosage\, for intramuscular use"
xref: cvx:161

[Term]
id: cpt:90686
name: Influenza\, split virus\, quadrivalent\, PF
def: "Influenza virus vaccine\, quadrivalent \(IIV4\)\, split virus\, preservative free\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:150

[Term]
id: cpt:90687
name: Influenza\, split virus\, quadrivalent\, preservative
def: "Influenza virus vaccine\, quadrivalent \(IIV4\)\, split virus\, 0.25 mL dosage\, for intramuscular use"
xref: cvx:158

[Term]
id: cpt:90688
name: Influenza\, split virus\, quadrivalent\, preservative
def: "Influenza virus vaccine\, quadrivalent \(IIV4\)\, split virus\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:158

[Term]
id: cpt:90690
name: typhoid\, oral
def: "Typhoid vaccine\, live\, oral"
xref: cvx:25

[Term]
id: cpt:90691
name: typhoid\, ViCPs
def: "Typhoid vaccine\, Vi capsular polysaccharide \(ViCPs\)\, for intramuscular use"
xref: cvx:101

[Term]
id: cpt:90692
name: typhoid\, parenteral
def: "Typhoid vaccine\, heat- and phenol-inactivated \(H-P\)\, for subcutaneous or intradermal use"
xref: cvx:41

[Term]
id: cpt:90693
name: typhoid\, parenteral\, AKD \(U.S. military\)
def: "Typhoid vaccine\, acetone-killed\, dried \(AKD\)\, for subcutaneous use \(U.S. military\)"
xref: cvx:53

[Term]
id: cpt:90694
name: Influenza\, adjuvanted\, quadrivalent\, PF
def: "Influenza virus vaccine\, quadrivalent \(aIIV4\)\, inactivated\, adjuvanted\, preservative free\, 0.5 mL dosage\, for intramuscular use"
xref: cvx:205

[Term]
id: cpt:90696
name: DTaP-IPV
def: "Diphtheria\, tetanus toxoids\, acellular pertussis vaccine and inactivated poliovirus vaccine \(DTaP-IPV\)\, when administered to children 4 through 6 years of age\, for intramuscular use"
xref: cvx:130

[Term]
id: cpt:90697
name: DTaP\,IPV\,Hib\,HepB
def: "Diphtheria\, tetanus toxoids\, acellular pertussis vaccine\, inactivated poliovirus vaccine\, Haemophilus influenzae type b PRP-OMP conjugate vaccine\, and hepatitis B vaccine \(DTaP-IPV-Hib-HepB\)\, for intramuscular use"
xref: cvx:146

[Term]
id: cpt:90698
name: DTaP-Hib-IPV
def: "Diphtheria\, tetanus toxoids\, acellular pertussis vaccine\, Haemophilus influenzae type b\, and inactivated poliovirus vaccine\, \(DTaP-IPV/Hib\)\, for intramuscular use"
xref: cvx:120

[Term]
id: cpt:90700
name: DTaP
def: "Diphtheria\, tetanus toxoids\, and acellular pertussis vaccine \(DTaP\)\, when administered to individuals younger than 7 years\, for intramuscular use"
xref: cvx:20

[Term]
id: cpt:90700
name: DTaP\, 5 pertussis antigens
def: "Diphtheria\, tetanus toxoids\, and acellular pertussis vaccine \(DTaP\)\, when administered to individuals younger than 7 years\, for intramuscular use"
xref: cvx:106

[Term]
id: cpt:90701
name: DTP
def: "Diphtheria\, tetanus toxoids\, and whole cell pertussis vaccine \(DTP\)\, for intramuscular use"
xref: cvx:01

[Term]
id: cpt:90702
name: DT \(pediatric\)
def: "Diphtheria and tetanus toxoids adsorbed \(DT\) when administered to individuals younger than 7 years\, for intramuscular use"
xref: cvx:28

[Term]
id: cpt:90703
name: tetanus toxoid\, adsorbed
def: "Tetanus toxoid adsorbed\, for intramuscular use"
xref: cvx:35

[Term]
id: cpt:90704
name: mumps
def: "Mumps virus vaccine\, live\, for subcutaneous use"
xref: cvx:07

[Term]
id: cpt:90705
name: measles
def: "Measles virus vaccine\, live\, for subcutaneous use"
xref: cvx:05

[Term]
id: cpt:90706
name: rubella
def: "Rubella virus vaccine\, live\, for subcutaneous use"
xref: cvx:06

[Term]
id: cpt:90707
name: MMR
def: "Measles\, mumps and rubella virus vaccine \(MMR\)\, live\, for subcutaneous use"
xref: cvx:03

[Term]
id: cpt:90708
name: M/R
def: "Measles and rubella virus vaccine\, live\, for subcutaneous use"
xref: cvx:04

[Term]
id: cpt:90710
name: MMRV
def: "Measles\, mumps\, rubella\, and varicella vaccine \(MMRV\)\, live\, for subcutaneous use"
xref: cvx:94

[Term]
id: cpt:90712
name: OPV\, Unspecified
def: "Poliovirus vaccine\, \(any type\[s\]\) \(OPV\)\, live\, for oral use"
xref: cvx:182

[Term]
id: cpt:90713
name: IPV
def: "Poliovirus vaccine\, inactivated \(IPV\)\, for subcutaneous or intramuscular use"
xref: cvx:10

[Term]
id: cpt:90714
name: Td \(adult\)\, 5 Lf tetanus toxoid\, preservative free\, adsorbed
def: "Tetanus and diphtheria toxoids adsorbed \(Td\)\, preservative free\, when administered to individuals 7 years or older\, for intramuscular use"
comment: "Beginning in 2005, this CPT code maps to TD preservative free. Remapped to CVX code 09 10/2021 to support active products mapped to that code."
xref: cvx:113

[Term]
id: cpt:90714
name: Td \(adult\)\, 2 Lf tetanus toxoid\, preservative free\, adsorbed
def: "Tetanus and diphtheria toxoids adsorbed \(Td\)\, preservative free\, when administered to individuals 7 years or older\, for intramuscular use"
comment: "Beginning in 2005, this CPT code maps to TD preservative free. Remapped to CVX code 09 10/2021 to support active products mapped to that code."
xref: cvx:09

[Term]
id: cpt:90715
name: Tdap
def: "Tetanus\, diphtheria toxoids and acellular pertussis vaccine \(Tdap\)\, when administered to individuals 7 years or older\, for intramuscular use"
xref: cvx:115

[Term]
id: cpt:90716
name: varicella
def: "Varicella virus vaccine \(VAR\)\, live\, for subcutaneous use"
xref: cvx:21

[Term]
id: cpt:90717
name: yellow fever live
def: "Yellow fever vaccine\, live\, for subcutaneous use"
xref: cvx:37

[Term]
id: cpt:90717
name: Yellow fever vaccine live - alt
def: "Yellow fever vaccine\, live\, for subcutaneous use"
xref: cvx:183

[Term]
id: cpt:90720
name: DTP-Hib
def: "Diphtheria\, tetanus toxoids\, and whole cell pertussis vaccine and Hemophilus influenza B vaccine \(DTP-Hib\)\, for intramuscular use"
xref: cvx:22

[Term]
id: cpt:90721
name: DTaP-Hib
def: "Diphtheria\, tetanus toxoids\, and acellular pertussis vaccine and Hemophilus influenza B vaccine \(DTaP/Hib\)\, for intramuscular use"
xref: cvx:50

[Term]
id: cpt:90723
name: DTaP-Hep B-IPV
def: "Diphtheria\, tetanus toxoids\, acellular pertussis vaccine\, hepatitis B\, and inactivated poliovirus vaccine \(DTaP-HepB-IPV\)\, for intramuscular use"
xref: cvx:110

[Term]
id: cpt:90724
name: influenza\, unspecified formulation
def: "Influenza virus vaccine"
xref: cvx:88

[Term]
id: cpt:90725
name: cholera\, unspecified formulation
def: "Cholera vaccine for injectable use"
xref: cvx:26

[Term]
id: cpt:90726
name: rabies\, unspecified formulation
def: "Rabies vaccine"
xref: cvx:90

[Term]
id: cpt:90727
name: plague
def: "Plague vaccine\, for intramuscular use"
xref: cvx:23

[Term]
id: cpt:90728
name: BCG
def: "BCG vaccine"
xref: cvx:19

[Term]
id: cpt:90730
name: Hep A\, unspecified formulation
def: "Hepatitis A vaccine"
xref: cvx:85

[Term]
id: cpt:90731
name: Hep B\, unspecified formulation
def: "Hepatitis B vaccine"
xref: cvx:45

[Term]
id: cpt:90732
name: pneumococcal polysaccharide PPV23
def: "Pneumococcal polysaccharide vaccine\, 23-valent \(PPSV23\)\, adult or immunosuppressed patient dosage\, when administered to individuals 2 years or older\, for subcutaneous or intramuscular use"
xref: cvx:33

[Term]
id: cpt:90733
name: meningococcal MPSV4
def: "Meningococcal polysaccharide vaccine\, serogroups A\, C\, Y\, W-135\, quadrivalent \(MPSV4\)\, for subcutaneous use"
xref: cvx:32

[Term]
id: cpt:90734
name: meningococcal MCV4P
def: "Meningococcal conjugate vaccine\, serogroups A\, C\, W\, Y\, quadrivalent\, diphtheria toxoid carrier \(MenACWY-D\) or CRM197 carrier \(MenACWY-CRM\)\, for intramuscular use"
xref: cvx:114

[Term]
id: cpt:90734
name: Meningococcal MCV4O
def: "Meningococcal conjugate vaccine\, serogroups A\, C\, W\, Y\, quadrivalent\, diphtheria toxoid carrier \(MenACWY-D\) or CRM197 carrier \(MenACWY-CRM\)\, for intramuscular use"
xref: cvx:136

[Term]
id: cpt:90735
name: Japanese encephalitis SC
def: "Japanese encephalitis virus vaccine\, for subcutaneous use"
xref: cvx:39

[Term]
id: cpt:90736
name: zoster live
def: "Zoster \(shingles\) vaccine \(HZV\)\, live\, for subcutaneous injection"
xref: cvx:121

[Term]
id: cpt:90737
name: Hib\, unspecified formulation
def: "Hemophilus influenza B"
xref: cvx:17

[Term]
id: cpt:90738
name: Japanese Encephalitis IM
def: "Japanese encephalitis virus vaccine\, inactivated\, for intramuscular use"
xref: cvx:134

[Term]
id: cpt:90739
name: HepB-CpG
def: "Hepatitis B vaccine \(HepB\)\, CpG-adjuvanted\, adult dosage\, 2 dose or 4 dose schedule\, for intramuscular use"
xref: cvx:189

[Term]
id: cpt:90740
name: Hep B\, high-dosage\, dialysis or IC
def: "Hepatitis B vaccine \(HepB\)\, dialysis or immunosuppressed patient dosage\, 3 dose schedule\, for intramuscular use"
xref: cvx:44

[Term]
id: cpt:90741
name: IG\, unspecified formulation
def: "Immunization\, passive; immune serum globulin\, human \(ISG\)"
xref: cvx:14

[Term]
id: cpt:90743
name: Hep B\, adolescent or pediatric
def: "Hepatitis B vaccine \(HepB\)\, adolescent\, 2 dose schedule\, for intramuscular use"
xref: cvx:08

[Term]
id: cpt:90743
name: Hep B\, adult
def: "Hepatitis B vaccine \(HepB\)\, adolescent\, 2 dose schedule\, for intramuscular use"
xref: cvx:43

[Term]
id: cpt:90744
name: Hep B\, adolescent or pediatric
def: "Hepatitis B vaccine \(HepB\)\, pediatric/adolescent dosage\, 3 dose schedule\, for intramuscular use"
xref: cvx:08

[Term]
id: cpt:90745
name: Hep B\, adolescent/high risk infant
def: "Hepatitis B vaccine\, adolescent/high risk infant dosage\, for intramuscular use"
xref: cvx:42

[Term]
id: cpt:90746
name: Hep B\, adult
def: "Hepatitis B vaccine \(HepB\)\, adult dosage\, 3 dose schedule\, for intramuscular use"
xref: cvx:43

[Term]
id: cpt:90747
name: Hep B\, high-dosage\, dialysis or IC
def: "Hepatitis B vaccine \(HepB\)\, dialysis or immunosuppressed patient dosage\, 4 dose schedule\, for intramuscular use"
xref: cvx:44

[Term]
id: cpt:90748
name: Hib-Hep B
def: "Hepatitis B and Haemophilus influenzae type b vaccine \(Hib-HepB\)\, for intramuscular use"
xref: cvx:51

[Term]
id: cpt:90750
name: zoster recombinant
def: "Zoster \(shingles\) vaccine \(HZV\)\, recombinant\, subunit\, adjuvanted\, for intramuscular use"
xref: cvx:187

[Term]
id: cpt:90756
name: Influenza\, MDCK\, quadrivalent\, preservative
def: "Influenza virus vaccine\, quadrivalent \(ccIIV4\)\, derived from cell cultures\, subunit\, antibiotic free\, 0.5 mL dosage\, for intramuscular use"
comment: "Effective 1/1/2018"
xref: cvx:186

[Term]
id: cpt:90758
name: Ebola Zaire vaccine\, live\, recombinant\, 1mL dose
def: "Zaire ebolavirus vaccine\, live\, for intramuscular use"
xref: cvx:204

[Term]
id: cpt:90759
name: HepB recombinant\, 3-antigen\, Al\(OH\)3
def: "Hepatitis B vaccine \(HepB\)\, 3-antigen \(S\, Pre-S1\, Pre-S2\)\, 10 mcg dosage\, 3 dose schedule\, for intramuscular use"
xref: cvx:220

[Term]
id: cpt:91300
name: COVID-19\, mRNA\, LNP-S\, PF\, 30 mcg/0.3 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 30 mcg/0.3 mL dosage\, diluent reconstituted\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 12/11/2020"
xref: cvx:208

[Term]
id: cpt:91301
name: COVID-19\, mRNA\, LNP-S\, PF\, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 100 mcg/0.5 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - BLA Licensed and EUA authorized"
xref: cvx:207

[Term]
id: cpt:91302
name: COVID-19 vaccine\, vector-nr\, rS-ChAdOx1\, PF\, 0.5 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, DNA\, spike protein\, chimpanzee adenovirus Oxford 1 \(ChAdOx1\) vector\, preservative free\, 5x1010 viral particles/0.5 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA submission withdrawn"
xref: cvx:210

[Term]
id: cpt:91303
name: COVID-19 vaccine\, vector-nr\, rS-Ad26\, PF\, 0.5 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, DNA\, spike protein\, adenovirus type 26 \(Ad26\) vector\, preservative free\, 5x1010 viral particles/0.5 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 2/27/2021"
xref: cvx:212

[Term]
id: cpt:91304
name: COVID-19\, subunit\, rS-nanoparticle\, adjuvanted\, PF\, 5 mcg/0.5 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, recombinant spike protein nanoparticle\, saponin-based adjuvant\, 5 mcg/0.5 mL dosage\, for intramuscular use"
comment: "Original and Fall COVID-19 vaccine starting 2023"
xref: cvx:313

[Term]
id: cpt:91304
name: COVID-19\, subunit\, rS-nanoparticle+Matrix-M1 Adjuvant\, PF\, 0.5 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, recombinant spike protein nanoparticle\, saponin-based adjuvant\, 5 mcg/0.5 mL dosage\, for intramuscular use"
comment: "Original and Fall COVID-19 vaccine starting 2023"
xref: cvx:211

[Term]
id: cpt:91305
name: COVID-19\, mRNA\, LNP-S\, PF\, 30 mcg/0.3 mL dose\, tris-sucrose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 30 mcg/0.3 mL dosage\, tris-sucrose formulation\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized for primary series and IC, EUA rescinded 8/31/202 for monovalent boosters"
xref: cvx:217

[Term]
id: cpt:91306
name: COVID-19\, mRNA\, LNP-S\, PF\, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 50 mcg/0.25 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorization rescinded 8/31/2022 for adult monovalent booster dose"
xref: cvx:207

[Term]
id: cpt:91307
name: COVID-19\, mRNA\, LNP-S\, PF\, 10 mcg/0.2 mL dose\, tris-sucrose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 10 mcg/0.2 mL dosage\, diluent reconstituted\, tris-sucrose formulation\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized, pediatric 5 yrs through 11 yrs dose requires dilution"
xref: cvx:218

[Term]
id: cpt:91308
name: COVID-19\, mRNA\, LNP-S\, PF\, 3 mcg/0.2 mL dose\, tris-sucrose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 3 mcg/0.2 mL dosage\, diluent reconstituted\, tris-sucrose formulation\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized for children under 5 yrs"
xref: cvx:219

[Term]
id: cpt:91309
name: COVID-19\, mRNA\, LNP-S\, PF\, 50 mcg/0.5 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 50 mcg/0.5 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized for pediatric, EUA rescinded 8/31/2022 for adult monovalent booster dose"
xref: cvx:221

[Term]
id: cpt:91310
name: COVID-19\, D614\, recomb\, preS dTM\, AS03 adjuvant add\, PF\, 5mcg/0.5mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, monovalent\, preservative free\, 5 mcg/0.5 mL dosage\, adjuvant AS03 emulsion\, for intramuscular use"
comment: "COVID-19 Vaccine - Potential EUA authorization booster dose"
xref: cvx:225

[Term]
id: cpt:91311
name: COVID-19\, mRNA\, LNP-S\, PF\, pediatric 25 mcg/0.25 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, preservative free\, 25 mcg/0.25 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized for ages 6 mo through 5 yrs"
xref: cvx:228

[Term]
id: cpt:91312
name: COVID-19\, mRNA\, LNP-S\, bivalent\, PF\, 30 mcg/0.3 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, bivalent spike protein\, preservative free\, 30 mcg/0.3 mL dosage\, tris-sucrose formulation\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 8/31/2022 bivalent booster ages 12+ yrs"
xref: cvx:300

[Term]
id: cpt:91313
name: COVID-19\, mRNA\, LNP-S\, bivalent\, PF\, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, bivalent\, preservative free\, 50 mcg/0.5 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 8/31/2022 bivalent booster for ages 18+ yrs, potential EUA ages 6 yrs through 17 yrs"
xref: cvx:229

[Term]
id: cpt:91314
name: COVID-19\, mRNA\, LNP-S\, bivalent\, PF\, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, bivalent\, preservative free\, 25 mcg/0.25 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 8/31/2022 bivalent booster for ages 6 yrs through 11 yrs"
xref: cvx:229

[Term]
id: cpt:91315
name: COVID-19\, mRNA\, LNP-S\, bivalent\, PF\, 10 mcg/0.2 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, bivalent spike protein\, preservative free\, 10 mcg/0.2 mL dosage\, diluent reconstituted\, tris-sucrose formulation\, for intramuscular use"
comment: "COVID-19 Vaccine - Potential EUA authorization bivalent booster for ages 5 yrs through 11 yrs"
xref: cvx:301

[Term]
id: cpt:91316
name: COVID-19\, mRNA\, LNP-S\, bivalent\, PF\, 10 mcg/0.2 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, bivalent\, preservative free\, 10 mcg/0.2 mL dosage\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 12/8/2022  bivalent booster (Moderna) for ages 6 mo through 5 yrs"
xref: cvx:230

[Term]
id: cpt:91317
name: COVID-19\, mRNA\, LNP-S\, bivalent\, PF\, 3 mcg/0.2 mL dose
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, bivalent spike protein\, preservative free\, 3 mcg/0.2 mL dosage\, diluent reconstituted\, tris-sucrose formulation\, for intramuscular use"
comment: "COVID-19 Vaccine - EUA authorized 12/8/2022  bivalent vaccine (Pfizer) for ages 6 mo through 4 yrs"
xref: cvx:302

[Term]
id: cpt:91318
name: COVID-19\, mRNA\, LNP-S\, PF\, tris-sucrose\, 3 mcg/0.3 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, 3 mcg/0.3 mL dosage\, tris-sucrose formulation\, for intramuscular use"
comment: "Fall COVID-19 vaccine starting 2023"
xref: cvx:308

[Term]
id: cpt:91319
name: COVID-19\, mRNA\, LNP-S\, PF\, tris-sucrose\, 10 mcg/0.3 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, 10 mcg/0.3 mL dosage\, tris-sucrose formulation\, for intramuscular use"
comment: "Fall COVID-19 vaccine starting 2023"
xref: cvx:310

[Term]
id: cpt:91320
name: COVID-19\, mRNA\, LNP-S\, PF\, tris-sucrose\, 30 mcg/0.3 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, spike protein\, 30 mcg/0.3 mL dosage\, tris-sucrose formulation\, for intramuscular use"
comment: "Fall COVID-19 vaccine starting 2023"
xref: cvx:309

[Term]
id: cpt:91321
name: COVID-19\, mRNA\, LNP-S\, PF\, 25 mcg/0.25 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, 25 mcg/0.25 mL dosage\, for intramuscular use"
comment: "Fall COVID-19 vaccine starting 2023"
xref: cvx:311

[Term]
id: cpt:91322
name: COVID-19\, mRNA\, LNP-S\, PF\, 50 mcg/0.5 mL
def: "Severe acute respiratory syndrome coronavirus 2 \(SARS-CoV-2\) \(coronavirus disease \[COVID-19\]\) vaccine\, mRNA-LNP\, 50 mcg/0.5 mL dosage\, for intramuscular use"
comment: "Fall COVID-19 vaccine starting 2023"
xref: cvx:312
